Premium
Nonalcoholic Fatty Pancreas Disease
Author(s) -
Shah Nihar,
Rocha Jason P.,
Bhutiani Neal,
Omer Endashaw
Publication year - 2019
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1002/ncp.10397
Subject(s) - medicine , insulin resistance , nonalcoholic fatty liver disease , steatosis , metabolic syndrome , pancreas , disease , malnutrition , clinical significance , obesity , gastroenterology , fatty liver
Nonalcoholic fatty pancreas disease (NAFPD) describes a phenotype of pancreatic steatosis (PS) that is not caused by alcohol consumption, viral infections, toxins, or congenital metabolic syndromes but is associated with insulin resistance, malnutrition, obesity, metabolic syndrome, or increasing age. NAFPD is a relatively new disease entity, as the clinical significance of fatty infiltration of pancreas has gained attention recently. Clinical consequences of NAFPD remain largely unknown despite clinical associations. This review aims to study similarities and differences between hepatic and PS and explore recent advances in NAFPD.